Showing results (121-130 of 302) with videos related to

Sort By:
Pageof 31
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 3, 2020
Two rapid, accurate liquid chromatography tandem mass spectrometry methods for the quantification of seven uremic toxins: An application for describing their accumulation kinetic profile in a context of acute kidney injuryCamille André, Youssef Bennis, Dimitri Titeca-Beauport, et al.
European Journal of Preventive Cardiology|July 15, 2025
Expert Perspectives on Incorporating GLP-1 RA in Diabetes and Chronic Kidney Disease - Challenges and OpportunitiesJean-Michel Halimi, Laurent Fauchier, Alexandre Karras, et al.
Nephrologie & Therapeutique|February 15, 2011
[Plasma malondialdehyde may not predict mortality in patient with chronic kidney disease]Aurélie Terrier-Lenglet, Aude Nollet, Sophie Liabeuf, et al.
Clinical Kidney Journal|November 8, 2016
The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patientsRodrigo Bueno de Oliveira, Sophie Liabeuf, Hirokazu Okazaki, et al.
Advances in Therapy|July 1, 2023
Factors That Predict a Sustained Humoral Response to COVID-19 Vaccines in Kidney Transplant RecipientsPierre Pommerolle, Pierre Laurent, Claire Presne, et al.
Nephrologie & Therapeutique|October 20, 2009
[Macroscopic hematuria and artery aneurysm]Marcos Kubrusly, Claudia Maria Costa De Oliveira, Marcello Otoch, et al.
The International Journal of Artificial Organs|October 16, 2012
Prognostic implications of plasma myoglobin levels in patients with chronic kidney diseaseAurélie Lenglet, Sophie Liabeuf, Lucie Desjardins, et al.
Nephron. Clinical Practice|November 13, 2010
Prognostic implication of plasma osteopontin levels in patients with chronic kidney diseaseDaniela V Barreto, Aurelie Lenglet, Sophie Liabeuf, et al.
Kidney International|August 17, 2012
Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patientsSophie Liabeuf, Aurélie Lenglet, Lucie Desjardins, et al.
Kidney International|December 18, 2009
Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney diseaseDaniela V Barreto, Fellype C Barreto, Sophie Liabeuf, et al.
Pageof 31